Chataway, Joanna; Brusoni, Stefano; Cacciatori, Eugenia; Hanlin, Rebecca and Orsenigo, Luigi
(2007).
| URL: | http://www.journalsonline.tandf.co.uk/content/q054... |
|---|---|
| DOI (Digital Object Identifier) Link: | http://dx.doi.org/doi:10.1080/09578810601144350 |
| Google Scholar: | Look up in Google Scholar |
Abstract
Vaccine production is now at the heart of the debate on development. This paper argues that, as well economic policies to address market failure, development policies aimed at fostering vaccine innovation should also consider the institutional and organisational uncertainities. The International AIDS Vaccine Initiative (IAVI), a product development PPP, is attempting to increase vaccine production for neglected diseases by acting both as broker and integrator of knowledge. Within IAVI and perhaps other PPPs there is a related tension between an emphasis on private pharmaceutical sector efficiency and sustainable development activities that requires understanding and managing if PPPs are to successfully reach their goals.
| Item Type: | Journal Article |
|---|---|
| ISSN: | 1743-9728 |
| Extra Information: | http://www.tandf.co.uk/journals/titles/09578811.asp |
| Keywords: | AIDS; innovation; neglected diseases |
| Academic Unit/Department: | Mathematics, Computing and Technology > Design, Development, Environment and Materials Social Sciences > Economics |
| Related URLs: |
|
| Item ID: | 7216 |
| Depositing User: | Jo Chataway |
| Date Deposited: | 26 Mar 2007 |
| Last Modified: | 02 Dec 2010 19:58 |
| URI: | http://oro.open.ac.uk/id/eprint/7216 |
Actions (login may be required)
| View Item | |
| Report issue / request change |